Publication | Open Access
Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study
43
Citations
21
References
2014
Year
The severity, symptoms, and nerve conduction parameters of DPN improved after 12 weeks of treatment with rosuvastatin. These beneficial effects appear to be attributable to reductions in lipid peroxidation and oxidative stress.
| Year | Citations | |
|---|---|---|
2001 | 8.9K | |
2006 | 536 | |
2001 | 458 | |
2003 | 403 | |
2011 | 270 | |
1993 | 200 | |
2013 | 144 | |
2003 | 110 | |
2005 | 105 | |
2011 | 104 |
Page 1
Page 1